Leishmaniases. Epidemiological Report in the Americas, February 2018
MetadataShow full item record
[Introduction]. The leishmaniasis are diseases with elevated incidence rate and wide geographic distribution in the Americas. They remain a challenge for national and regional programs, since they require a technical, operative and political effort to sustain the systematic development of surveillance, prevention and control actions towards these diseases. In 2017, delegates of the endemic countries, who attended the Regional Leishmaniasis Meeting, approved the Leishmaniasis Plan of Action 2017-2022 for the Americas, which details the goals, indicators and actions to reinforce the commitments of PAHO's Directing Council Resolution CD55.R9 of 2016. The objective of the Plan is to reduce morbidity and mortality by leishmaniasis in the Region through strengthening of the diagnosis, treatment, rehabilitation, prevention, surveillance and control. It also has four regional goals which are to be reached by 2022: 1) Reduce the visceral leishmaniasis fatality rate by 50%; 2) reduce cutaneous/mucosal leishmaniasis deaths by 90%; 3) reduce the proportion of cutaneous leishmaniasis in children under 10 years old by 50%; and 4) reduce the visceral leishmaniasis incidence according to the epidemiological scenario of each country.
Table of contents
Introduction | Epidemiological status: Cutaneous and mucosal leishmaniasis; Visceral leishmaniasis | Final considerations
Category of PAHO Strategic Plan 2014-2019
Showing items related by title, author, creator and subject.
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (Washington, D.C., PAHO, 2021-12-13)The Pan American Health Organization (PAHO) continues to support endemic countries in order to achieve the objectives of controlling and eliminating leishmaniasis as a public health problem in the Region, in accordance ...
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (Washington, D.C., PAHO, 2022-12-08)This report presents a detailed analysis of 2021 data on leishmaniases in the Region of the Americas and includes a series of infographics with specific data on cutaneous and mucosal leishmaniasis in endemic countries. In ...
Pan American Health Organization (Washington, D.C., PAHO, 2016-07)[Introduction]. The leishmaniases are vector-borne diseases with a zoonotic cycle in the Americas and remain a problem to public health. This disease presents a high burden capable of yielding severe clinical forms that ...